Tag: Factor replacement therapy

In the United States, hemophilia is estimated to affect between 30,000 and 33,000 males [1.9.1]. The question, 'What is the drug of choice for hemophilia?' does not have a single answer, as treatment is highly individualized based on the type, severity, and patient-specific factors.

The timely use of the right medication can be critical in controlling life-threatening hemorrhage, with studies showing that early administration of agents like tranexamic acid can significantly improve survival rates in trauma patients. To understand what drug controls bleeding effectively, it is essential to explore the various classes of hemostatic agents that support the body's natural clotting mechanisms.